November 11, 2016

Today's Top Alzheimer's News

USA2 SPOTLIGHT

A November 10, 2016 Latin Post article reported that “experts say that these three things can calm such dangerous surge: better diagnostics and drugs, more money for research, victory that would boost morale.” According to the article, “According to co-founder and chair of UsAgainstAlzheimer's, non-profit organization in Maryland Chevy Chase, George Vradenburg, said that one problem of the disease is the visibility cause ‘there wasn't any comparable upswell of attention to Alzheimer’s.’”


MUST READS

A November 11, 2016 Forbes.com article profiled “Solanezumab And The History Of The Future Of Treating Alzheimer's Disease.” According to the article, “The drug Lilly is testing, solanezumab, or “sola” for short, targets amyloid. If Expedition 3 shows that patients on sola “do better” than patients on placebo, the field’s long adolescence will end, and Alzheimer’s doctors will have a new drug to prescribe and also a new way to talk about the disease. They’ll likely start calling it a “disorder of amyloid accumulation.”

A November 10, 2016 The Verge article explored the possible impact of Donald Trump’s election on medical research funding. According to the article, “But just because Trump thinks the NIH is terrible doesn’t mean he won’t fund it, if his comments to Scientific American are any guide. He said in September that “there are increasing demands to curtail spending and to balance the federal budget, we must make the commitment to invest in science, engineering, healthcare and other areas that will make the lives of Americans better, safer and more prosperous.” On its part, the NIH says it’s ready for the transition. “NIH has a long history of bi-partisan support and stands ready to work with the new Administration to improve people's health and reduce the burden of disease through biomedical research,” Amanda Fine, a PR officer for the NIH, wrote in an email to The Verge.”

A November 10, 2016 Psychiatry Advisor article reported that “Magnetic resonance imaging (MRI) of the brain may aid diagnosis of dementia with Lewy bodies versus Alzheimer's disease, according to a study published online Nov. 2 in Neurology.”

A November 10, 2016 ABC.net article reported that “A simple eye test could determine if a person is likely to develop Alzheimer's disease decades before they show symptoms, a leading US medical scientist says.”